Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2007-8-8
pubmed:abstractText
Brain microinjection studies in the rat using local anesthetics suggest that the rostral ventral medulla (RVM) contributes to the facilitation of neuropathic pain. However, these studies were restricted to a single model of neuropathic pain (the spinal nerve ligation model) and to just two stimulus modalities (non-noxious tactile stimulus and heat). Also, few neurotransmitter systems have been shown to modulate descending facilitation. After either partial sciatic nerve ligation (PSNL) or spared nerve injury (SNI), we found that unilateral or bilateral microinjection of lidocaine into the RVM reduced not only mechanical allodynia (decreased threshold to von Frey hairs and/or an automated device) and mechanical hyperalgesia (increased paw lifting in response to a noxious pin), but also cold hypersensitivity (increased lifting in response to the hindpaw application of a drop of acetone). Application of a drop of water did not elicit paw withdrawal, indicating that the acetone test is indeed a measure of cold hypersensitivity. We found significant neuropeptide Y Y1-like immunoreactivity within, and lateral to, the midline RVM. Intra-RVM injection of neuropeptide Y (NPY) dose-dependently inhibited the mechanical and cold hypersensitivity associated with PSNL or SNI, an effect that could be blocked by the Y1 receptor antagonist BIBO 3304. We conclude that medullary facilitation spans multiple behavioral signs of allodynia and hyperalgesia in multiple models of neuropathic pain. Furthermore, NPY inhibits behavioral signs of neuropathic pain, possibly by acting at Y1 receptors in the RVM.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-10924808, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-11062340, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-11149671, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-11252149, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-11438603, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-11826044, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-11973010, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-12031341, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-12086751, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-12435453, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-12900925, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-12911621, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-14622753, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-15219260, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-15271725, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-15982817, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-16039797, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-1674413, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-1982347, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-2864784, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-6379758, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-7616212, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-7990513, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-8564255, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-8945744, http://linkedlifedata.com/resource/pubmed/commentcorrection/17276005-9063706
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1872-6623
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
131
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
83-95
pubmed:dateRevised
2011-5-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Neuropeptide Y acts at Y1 receptors in the rostral ventral medulla to inhibit neuropathic pain.
pubmed:affiliation
Department of Pharmacology, School of Medicine, Tulane University, New Orleans, LA 70112, USA. taylorb@tulane.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural